Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-32,693
Closed -$1.33M 540
2025
Q4
$1.33M Sell
32,693
-15,065
-32% -$655K 0.09% 308
2025
Q3
$2.25M Buy
47,758
+43,657
+1,065% +$2.26M 0.14% 238
2025
Q2
$214K Hold
4,101
0.01% 633
2025
Q1
$248K Sell
4,101
-29,597
-88% -$1.91M 0.02% 646
2024
Q4
$2.31M Sell
33,698
-13,579
-29% -$946K 0.2% 172
2024
Q3
$3.4M Sell
47,277
-16,723
-26% -$1.18M 0.3% 91
2024
Q2
$4.44M Buy
64,000
+51,815
+425% +$3.78M 0.42% 46
2024
Q1
$976K Buy
12,185
+2,785
+30% +$248K 0.09% 338
2023
Q4
$1.03M Buy
9,400
+1,525
+19% +$158K 0.11% 282
2023
Q3
$794K Sell
7,875
-1
-0% -$115 0.1% 339
2023
Q2
$1.07M Buy
7,876
+2,191
+39% +$267K 0.15% 235
2023
Q1
$590K Buy
5,685
+2,420
+74% +$234K 0.08% 370
2022
Q4
$289K Buy
+3,265
New +$271K 0.05% 490
2020
Q1
Sell
-2,700
Closed -$302K 680
2019
Q4
$302K Buy
+2,700
New +$288K 0.02% 538
2015
Q4
Sell
-7,410
Closed -$354K 500
2015
Q3
$354K Buy
+7,410
New +$407K 0.01% 1007
2014
Q3
Sell
-37,806
Closed -$1.67M 1343
2014
Q2
$1.67M Buy
37,806
+26,857
+245% +$1.22M 0.04% 501
2014
Q1
$476K Buy
+10,949
New +$488K 0.01% 975

Other funds holding CNMD

PDT Partners's CNMD Position: Q1 2026 in Review

PDT Partners sold out of CONMED (CNMD) in Q1 2026, closing a stake of 32,693 shares — an estimated $1.33M sold.

PDT Partners first reported a position in CNMD in Q1 2014 and held it in 17 quarters. The position peaked at $4.44M in Q2 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • PDT Partners reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • PDT Partners sold 32,693 CONMED shares in Q1 2026, an estimated $1.33M.
  • PDT Partners first reported a position in CONMED in Q1 2014 and held it in 17 quarters.
  • PDT Partners's CONMED position peaked at $4.44M in Q2 2024.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.